Using a PerkinElmer Opera Phenix Imaging System and proprietary analytic algorithms, a team of Austrian scientists developed Pharmacoscopy, a method to rapidly screen existing drugs for potential use in cancer immunotherapy.

Research at Institut Pasteur de Lille using PerkinElmer’s Opera® High-Content Screening System and Acapella® Image Analysis Software contributes substantial new information to our understanding of M. tuberculosis.

Cancer researchers now can visualize more of a tumor than ever before using PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions. In a melanoma case study, Dr. Tumeh uses this instrumentation to develop biomarkers in his cancer immunology research.

Using the Attivo and SciBite TERMite platforms, researchers can now unlock the value of unstructured data found in electronic medical records, to reveal medical discoveries that would otherwise be lost in too much data.

A new generation of high-content imaging systems such as the PerkinElmer Operetta CLS High Content Imaging System and Harmony High Content Imaging and Analysis Software are helping scientists to blaze new trails in cancer drug therapy.

Scientists at UCLA's David Geffen School of Medicine are working with bioluminescent, fluorescent, and positron emission tomography (PET) technologies to reduce infections in post-surgical orthopedic patients as well as fight against metabolic cancer.

Customer Care

Connect

NOTICE: You are now leaving the PerkinElmer website. The privacy policy of the site to which you are going may differ from PerkinElmer's privacy policy. To remain at the PerkinElmer site and return to your previous page, click the button Cancel. To leave the PerkinElmer site for the link you selected, click the button OK.